MARSHALL HEALTHCARE
GST : 24CJWPK9058H1ZI

Call us now

08045814116

Send Inquiry

Request To Call Back

Alluvi Retatrutide 40mg Injection Pen

Name: Alluvi Retatrutide 40mg Injection Pen
Brand: MARSHALL HEALTHCARE
Price: 5450.0 INR
Availability: InStock

Price 5450.0 INR/ Unit

Get a Price/Quote

MOQ : 5 Units

Alluvi Retatrutide 40mg Injection Pen Specification

Brand Name
Alluvi Retatrutide

Drug Type
Injection

Ingredients
Alluvi Retatrutide 20 mg refers to a research-grade formulation derived from Eli Lilly s investigational compound Retatrutide (LY3437943). It is a GLP-1, GIP and glucagon triple-agonist peptide being studied for its potential to regulate appetite, glucose levels, and overall energy expenditure. Its mechanism activates three incretin pathways simultaneously, which may lead to greater fat-loss effects and improved metabolic control compared with current single- or dual-agonist drugs.

Alluvi Retatrutide 40mg Injection Pen Trade Information

Minimum Order Quantity
5 Units

Delivery Time
5 Days

About Alluvi Retatrutide 40mg Injection Pen

Alluvi Retatrutide 40 mg refers to a research-grade formulation derived from Eli Lillys investigational compound Retatrutide (LY3437943).

It is a GLP-1, GIP and glucagon triple-agonist peptide being studied for its potential to regulate appetite, glucose levels, and overall energy expenditure.

Unlike approved weight-loss injections such as Wegovy (semaglutide) or Mounjaro (tirzepatide), Alluvi Retatrutide 20 mg remains in clinical trials.
Its mechanism activates three incretin pathways simultaneously, which may lead to greater fat-loss effects and improved metabolic control compared with current single- or dual-agonist drugs.

Triple-Agonist Mechanism for Advanced Metabolic Research

Alluvi Retatrutide 40mg Injection Pen leverages a powerful mechanism by activating GLP-1, GIP, and glucagon pathways in the body. This triple-agonist approach sets it apart from more traditional peptides, with studies suggesting the potential for greater fat loss, better appetite suppression, and improved glucose regulation. It holds promise for researchers studying new interventions for metabolic disorders.

Optimized Delivery with Injection Pen Technology

The Alluvi Retatrutide formulation is provided in a convenient injection pen, offering precise dosing and ease of use for research purposes. This method ensures effective delivery and reproducibility during experimental setups, supporting robust and repeatable scientific investigation.

FAQ's of Alluvi Retatrutide 40mg Injection Pen:

Q: How does Alluvi Retatrutide 40mg Injection Pen function within metabolic research?

A: Alluvi Retatrutide operates by engaging three key incretin hormone pathways-GLP-1, GIP, and glucagon receptors-thereby influencing appetite control, energy expenditure, and glucose metabolism. Its triple-agonist action may produce more robust outcomes in metabolic regulation research compared to agents with fewer targets.

Q: What is the primary benefit of using a triple-agonist peptide like Alluvi Retatrutide for studies?

A: Researchers may observe enhanced fat loss, improved glucose regulation, and potentially greater energy expenditure due to the simultaneous activation of multiple metabolic pathways, offering broader insights beyond single- or dual-pathway incretin therapies.

Q: Where can Alluvi Retatrutide 40mg Injection Pen be sourced for research purposes?

A: Alluvi Retatrutide is distributed, exported, and supplied by authorized wholesalers, suppliers, and service providers specializing in research-grade compounds and laboratory materials. It is not intended for clinical or therapeutic use.

Q: When is Alluvi Retatrutide 40mg Injection Pen typically utilized in research?

A: This product is typically employed during advanced metabolic studies, particularly those investigating novel weight management strategies, glucose regulation mechanisms, or multi-pathway peptide interventions.

Q: What is the correct process for using the Alluvi Retatrutide Injection Pen in a research setting?

A: Researchers should follow established protocols for subcutaneous injection, using the pen for accurate dosage administration and proper sterile technique to ensure reliable experimental results.

Q: How does Alluvi Retatrutide differ from conventional single-agonist GLP-1 analogues?

A: Unlike single-agonist drugs, Alluvi Retatrutide acts on three separate incretin receptors concurrently. This broader mechanism may reveal new physiological responses and distinct research outcomes.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Pharmaceutical Injection Category

Octreotide Octride 50 Mg 1 Ml Injection

Price 1400.00 INR / Box

Minimum Order Quantity : 500 Boxes

Ingredients : OCTREOTIDE 50 MCG / 100 MCG INJECTION 1ML

Physical Form : Liquid

Quantity : 5 ampules of 1ml Boxes

Get a Price/Quote

Synedica Retatrutide 40mg Injection Pen

Price 5700.0 INR / Box

Minimum Order Quantity : 5 Boxes

Ingredients : Synedica Retatrutide

Brand Name : Synedica Retatrutide

Physical Form : Other

Quantity : 5 Boxes

Get a Price/Quote

Synedica Retatrutide 40mg Injection Pen For weight Loss

Price 5600.0 INR / Box

Minimum Order Quantity : 5 Boxes

Ingredients : Synedica Retatrutide Injection Pen

Brand Name : Synedica Retatrutide

Physical Form : Other

Quantity : 5 Unit

Get a Price/Quote

VLS Retatrutide 20mg injection Pen

Price 5100.0 INR

Minimum Order Quantity : 5 Boxes

Ingredients : VLS Retatrutide and VLS Retatrutide 40 mg is a synthetic peptide compound studied within metabolic and endocrine research. It belongs to a class of compounds designed to interact with multiple hormone receptors involved in physiological regulation.

Brand Name : VLS Retatrutide

Quantity : 5 Unit

Get a Price/Quote